June 16, 2016

Seton Hall's U.S. Healthcare Compliance Certification Program

Being the Focus of a Government Investigation

Overview

Florham Park partner Lynne Anderson, along with Washington, D.C. partner Peter Blenkinsop and counsel Katherine Armstrong spoke at Seton Hall’s U.S. Healthcare Compliance Certification Program, June 13-16.

The event offered a comprehensive overview of state, federal and international law governing prescription drugs, medical devices and health care fraud. Topics included privacy and data protection; FDA approval and regulation; anti-kickback laws; federal and state false claims acts; Sunshine Law; Foreign Corrupt Practices Act; government investigations; health care fraud sentencing, penalties and damages; OIG Compliance; and prescription drug and device marketing. Attendees included representatives from pharmaceutical companies and hospitals.

Lynne participated in the panel titled, “Being the Focus of a Government Investigation” which provided the perspective of dealing with an employee whistleblower. She was joined by Mike Doyle of the Federal Bureau of Investigation; Jacob Elberg of the U.S. Attorney’s Office, District of New Jersey; Maureen Ruane of Lowenstein Sandler P.C.; and Jim Sheehan of the Office of the New York Attorney General. Professor Timothy Glynn of Seton Hall Law School moderated.

Peter and Katherine gave a presentation titled “Why Data Privacy Matters: Understanding, Risks, Benefits and Strategy,” providing insight into identifying and addressing compliance risks and building effective compliance programs.

Learn more about the event.

Services and Industries

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.